Prescription of cardiovascular medication in children with congenital heart defects across six European Regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort study
Mads Damkjær(University of Southern Denmark), Joan K. Morris(St George's, University of London), Joanne Given(University of Ulster), Aurora Puccini(University of Bologna), Laia Barrachina‐Bonet(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Clara Cavero‐Carbonell(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Alessio Coi(Istituto di Fisiologia Clinica), Ester Garne(University of Southern Denmark), Ieuan Scanlon(Swansea University), Anna Heino(Finnish Institute for Health and Welfare), Anna Pierini(Istituto di Fisiologia Clinica), Stine Kjær Urhøj(Lillebaelt Hospital), Sonja Kiuru‐Kuhlefelt(Finnish Institute for Health and Welfare), Joachim Tan(St George's, University of London), Gillian Briggs(St George's, University of London), Amanda J. Neville(University of Ferrara), Maria Loane(University of Ulster)
Cited by 8
Related Papers
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
|The American Journal of Medicine|2009|941
Cardiovascular morbidity and mortality after orthotopic liver transplantation
|Transplantation|2002|326
Child–Parent Familial Hypercholesterolemia Screening in Primary Care
|New England Journal of Medicine|2016|317
Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study
|Archives of Disease in Childhood Fetal & Neonatal|2014|311